The Human Primary Cells Market is set to grow at a CAGR of 7% by 2026 as the increasing application in the cosmetics and medical research industry is fueling the demand for human primary cells.


Human Primary cells are being extensively used in research & development activities in the pharmaceutical and biotechnology fields. Medical research industry is the largest user of human primary cells in the present scenario. In this industry, human primary cells are used in various studies related to chronic diseases such as cancer, asthma, diabetes and others.  Apart from this, demand for certain types of cells has been witnessing consistent rise in the cosmetics industry.

“Cosmetics companies are heavily investing in R&D in order to match consumer requirements. Complex formulations using variety of active ingredients require proper testing during the course of their development. The Human Primary Cells Market is contributing to the rising demand of primary cells such as Fibroblasts, Keratinocytes and others in the cosmetics industry”. 

Presently, the demand for these cells is more concentrated in the developed regions. In 2017, North America and Europe collectively accounted for more than 50% of the overall market share. However, rising expenditure in pharmaceutical research activities in the Asia Pacific region would offer business opportunities to the players operating in the human primary cells market. Several major players have been strengthening their presence and distribution network in emerging markets in order to capitalize upon the business opportunities.

The detailed research study provides qualitative and quantitative analysis of the very market. The human primary cells market has been analyzed from demand as well as supply side. The demand side analysis covers market revenue as well as sales volume across regions and further, across all the major countries. The supply side analysis covers regional production volume and capacity analysis. The geographical analysis done emphasizes on each of the major countries across North America, Europe, Asia Pacific, Middle East, Africa and Latin America.

Some of the major players operating in the human primary cell market are Lonza, Thermo Fisher Scientific, Sigma-Aldrich, Cell Biologics, PromoCell GmbH, Cureline, Zen-Bio, Stemcell Technologies, Pelobiotech, among the others.

By Type 

  • Blood (peripheral) cells
  • Endothelial cells
  • Epithelial cells
  • Fibroblast cells
  • Hepatocyte cells
  • Keratinocyte cells
  • Melanocyte cells
  • Pancreatic cells
  • Smooth muscle cells
  • Skeletal cells
  • Adipocyte cells

By Application

  • Pharmaceutical
  • Biotechnology
  • Cosmetics
  • Academia

By Geography

  • North America
    • U.S.
    • Rest of North America
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Middle East and Africa
    • GCC Countries
    • Southern Africa
    • Rest of Middle East and Africa
  • Latin America
    • Brazil
    • Rest of Latin America